TOLMAR is a fully integrated pharmaceutical company focused on the development, approval, and commercialization of specialty pharmaceutical products, including a line of generic dermatology products, where TOLMAR is an established leader, and specialty injectable oncology products. Invention, development, and world-wide approval of ELIGARD for the palliative treatment of advanced prostate cancer has established TOLMAR as a leader dedicated to the urology community, providers, and patients. TOLMAR Pharmaceuticals is based in Lincolnshire, Illinois with TOLMAR headquarters, product development and manufacturing facilities based in Fort Collins, Colorado.

701 Centre Ave Fort Collins, CO 80526
Tel: 970-212-4500